Case Report
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Jun 27, 2023; 15(6): 1232-1239
Published online Jun 27, 2023. doi: 10.4240/wjgs.v15.i6.1232
Figure 1
Figure 1 Pseudoaneurysm bleeding after atezolizumab–bevacizumab treatment. A: Magnetic resonance imaging (MRI) of the abdomen revealed multifocal enhancing hepatocellular carcinoma lesions in the liver (white arrows); B: After transcatheter arterial chemoembolization and lenvatinib treatment, MRI showed disease progression (white arrows); C and D: After three cycles of atezolizumab plus bevacizumab, MRI showed progressive disease (white arrows) but no remarkable gastroesophageal varices (white arrowhead).